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Abstract 
 
Protein crystallization is of strategic and commercial relevance in the post-genomic 
era, due to its pivotal role in structural proteomics projects. Although protein 
structures are crucial for understanding the function of proteins and to the success of 
rational drug design and other biotechnology applications, obtaining high quality 
crystals is a major bottleneck to progress. The major means of obtaining crystals is by 
massive-scale screening of a target protein solution with numerous crystallizing 
agents. However when crystals appear in these screens, one cannot easily know if 
they are crystals of protein, salt or any other molecule that happens to be present in 
the trials. We present here a method based on ATR-FTIR imaging that reliably 
identifies protein crystals through a combination of chemical specificity and the 
visualising capability of this approach, thus solving a major hurdle in protein 
crystallization. ATR-FTIR imaging was successfully applied to study the 
crystallization of thaumatin and lysozyme in a high-throughput manner, 
simultaneously from six different solutions. This approach is fast as it studies protein 
crystallization in situ and provides an opportunity to examine many different samples 
under a range of conditions.   
 
 
 
 
 
INTRODUCTION 
 
Determination of protein structures is key to understanding the function of proteins 
which are of industrial and medical interest. The most powerful method for 
determining the structure of proteins is x-ray crystallography which is totally reliant 
on the availability of high quality crystals.1 Structural proteomics, which aims to 
determine the structures of thousands of proteins, has therefore generated great 
pressure to produce suitable crystals.  
 
The past six years have seen major achievements in the field of protein crystallization. 
Progress in the miniaturisation and automation of crystallization experiments is 
making it possible to deal with the overwhelming numbers of proteins that are 
handled. It is now feasible to screen thousands of potential crystallization conditions 
by dispensing trials consisting of nanolitre volumes in a high throughput mode. This 
has cut the time of setting up experiments from weeks to minutes, a scenario that was 
unimaginable a few years ago.2 However, in spite of the ability to generate numerous 
trials, so far only a small percentage of the proteins produced have led to structure 
determination. High throughput has not yet resulted in high output. 
 
Table 1 shows a summary of results from most of the structural genomics/proteomics 
projects worldwide on 5th January 2009, demonstrating the attrition rate on going 
from cloned gene to structure. The results demonstrate that even when proteins can be 
expressed and made highly pure and soluble, this still does not guarantee useful 
crystals which will lead to structures.   
Table 1. Summary of all Major Structural 
Genomics Projects on 2 March 2009
From http://targetdb.pdb.org
4258 Structure defined
5894   Diffracting crystals
33365   Purified
36317     Soluble
92998     Expressed
139333    Cloned
Summary of all Major Structural 
Genomics Projects on 2 April 2009
From http://targetdb.pdb.org
4445 Structure defined
6175   Diffracting crystals
34229  Purified
36717    Soluble
95825      Expressed
142611    Cloned
 
The first step in obtaining crystals is to expose the proteins to be crystallized to 
numerous different crystallization agents in order to identify potential crystallization 
conditions. Once a “hit” deemed to be conducive to crystallization is identified, 
conditions are optimised in an attempt to obtain high quality crystals for subsequent 
structural analysis.  Surprisingly, crystals or crystalline precipitate are routinely 
considered leads that are worth pursuing.   A very common problem, however, is that 
when one can see crystals there is no simple way of knowing if they are crystals of 
protein or of another molecule arising from the crystallization agents, such as salt. In 
order to know definitively, one must x-ray them, but if they are too small even in one 
dimension, no crystal will x-ray properly. This means that one needs to obtain larger 
versions of these crystals which can waste a considerable amount of time, effort and 
consumables on possibly optimising the wrong conditions, and, the often inevitable 
frustration of harvesting crystals and x-raying them just to find out that they are not 
protein crystals. It is therefore vital to have reliable methods to distinguish between 
protein and other types of crystals.  
 
Currently, several methods are available to indicate whether crystals are 
proteinaceous without having to x-ray them, but all have drawbacks. One method 
involves inserting a Coommasie Brilliant Blue dye into the crystallization drop which 
will colour protein crystals blue, but this method is intrusive and may harm the 
crystals. Another means is called the ‘crush test’ whereby crystals are touched with a 
needle. If they disintegrate easily they are likely to be protein which means that a 
precious protein crystal is lost. However, it can also mean that the disintegrated 
crystals are of the buffer or an additive that is in the trial. 
 
With respect to spectroscopic methods, again, several options have been explored. A 
recent method to distinguish between salt and protein crystals is UV fluorescence 
imaging,3, 4 which results from fluorescing amino acids in a protein. Most of the 
intrinsic fluorescence emissions of a folded protein are due to excitation of tryptophan 
residues. However, disulfide bonds also have appreciable absorption in this 
wavelength range. Thus, any observed UV fluorescence could also be accounted for 
by some additive or other molecule that is not necessarily protein contributing to the 
spectral response.  This problem may not be widespread, since disulfide bonds are not 
always present in additives, and in the cases when they are present and absorb UV 
radiation then they may not necessarily fluoresce at the same wavelength as proteins. 
In contrast, chemical imaging, based on infrared spectroscopy, has much greater 
chemical specificity due to characteristic absorption bands in the infrared region,5 and 
provides an opportunity not only to identify protein crystals but also to determine 
secondary structures of proteins. In this paper we present a method, based on 
Attentuated Total Reflection (ATR)–Fourier Transform Infrared (FTIR) spectroscopic 
imaging, that has not been used for protein crystallization screening to date and can 
reliably distinguish protein crystals from any other type of crystals  in arrays of small 
volume (< 1microlitre) crystallization drops. The novel use of ATR-IR presented here 
is for screening to analyse whether any crystals or precipitates that are formed contain 
protein. This information informs a decision on whether the conditions are worth 
pursuing and optimising. Subsequent steps are then done outside the ATR-IR 
apparatus in crystallization vessels appropriate for specific crystal optimisation. 
 
 
FTIR spectroscopy is known as a powerful analytical method to analyse a wide range 
of materials. The infrared spectra of different materials are very specific and can be 
used as fingerprints for their identification. The advancement in multi-pixel infrared 
detectors (the focal plane array or FPA detector) has brought fast imaging capability 
to this analytical tool with the measurement of thousands of spectra simultaneously in 
a few minutes or even seconds.6, 7 This allows the measurement of chemically-specific 
images without the need of added dye or stain.  The appropriate comparison with 
ATR-FTIR imaging as a screening technique would be a confocal Raman microscopy.  
Chemically-specific confocal Raman spectroscopy can also be applied in situ to 
differentiate protein crystals,8 but it requires much longer measurement times 
(because it is not an imaging approach) and also time for preparation prior to the 
measurement. Each crystal has to first be located under the confocal microscope and 
conditions (confocal depth, laser power, exposure time, etc.) need to be optimised 
before a decent spectrum is obtained. Confocal Raman microscopy is not amenable to 
imaging of many wells simultaneously, but rather consequently where each sample is 
measured separately. Although wet samples are often regarded as challenging samples 
for infrared spectroscopy due to the strong absorption of water in the mid-IR region, 
this has been overcome when using ATR as the sampling method. In ATR 
measurements, the effective pathlength is determined by the refractive indices of the 
internal reflection element, the wavelength and the angle of incidence of infrared 
light.9 In general, the ATR approach would result in an effective pathlength of a few 
micrometers which is suitable for the measurement of wet samples or aqueous 
solutions. Previous studies have successfully utilised the advantage of ATR-FTIR 
imaging to study dissolution of tablets and pharmaceutical formulations in water. 10, 11 
It is also important to note that with a macro ATR-FTIR imaging approach described 
here it is not necessary to employ a microscope unlike with confocal Raman 
microscopy. 
 
In this work, we apply this methodology to study protein crystallization from a 
supersaturated protein solution. There are mainly two advantages using ATR-FTIR 
imaging for this. The first advantage is that protein and other types of crystals are 
readily distinguishable with FTIR spectroscopy without ambiguity. No dye or any 
additives are needed for the identification purpose. Infrared spectra of protein crystals 
can be extracted from the imaging measurement for further analysis. Secondly, 
samples are being measured in situ therefore there is no need to retrieve samples from 
the cultivating environment. Measurements can also be made at any time during the 
cultivation for the possible detection of early onsets of protein crystals. We also 
demonstrate the possibility of measuring multiple samples deposited in an array to 
render this approach readily applicable for high-throughput optimisation.  
 
EXPERIMENTAL SECTION 
 
Materials. Three proteins were tested: lysozyme, thaumatin and the membrane 
protein, CD81. A solution of lysozyme was prepared at 60mg/mL by dissolving 180 
mg lysozyme powder from Sigma (L6876) in 3 mL of sodium acetate buffer at pH 
4.6. 6 % w/v sodium chloride (from Sigma) was prepared by dissolving the powder in 
deionised water. 0.8-1 μL crystallization drops were made by mixing equal volumes 
of the protein and salt solutions. Thaumatin solution was prepared at 30 mg/mL by 
dissolving 6 mg of thaumatin powder (SigmaT7638) in 200 μL 0.1M Bis-Tris pH 6.8 
(BDH). 0.8 μL crystallization drops were made by mixing equal volumes of the 
protein solution with 1.1M sodium potassium tartrate (BDH).  The membrane protein 
CD81 was prepared as described.12  Since CD81 protein has a very low solubility in 
water, the detergent β-octylglucoside was added to the protein solution prior to 
subjecting it to crystallization trials following a ‘lead’ found by routine mass 
screening. 0.8 μL drops were made by mixing equal volumes of the protein and the 
‘lead’ crystallizing solution of 0.2M calcium chloride, 45 % MPD and  0.1 M Bis-Tris 
pH 5.5. Paraffin oil was purchased from BDH Laboratory Supplies. All experiments 
were set up at 20 oC. X-ray diffraction measurements were made on a PX scanner 
from Oxford Diffraction.  
 Instrumentation. For the measurement of a single sample per image, 0.5 μl protein 
solution was manually deposited directly onto the measuring surface of the ATR 
element (coupled with a ZnSe crystal accessory (Oil Analyzer, Specac Ltd) having an 
imaged area of approximately 2.5 x 3.6 mm2, and a diamond accessory (Golden Gate, 
Specac Ltd) adapted for imaging experiments with an imaged area of approximately. 
600 x 800 μm2) which is supersaturated by adding an equal amount of salt solution. 
The protein and salt solution mixture was sealed by surrounding the solution drop 
with paraffin oil (see Fig. 1, Scheme 1). For the measurement of multiple samples (i.e. 
in a high-throughput manner), a wax grid was first printed onto the measurement 
surface of the internal reflection element by using the microdroplet system 
(AutoDrop®, MicroDrop, Germany), creating square mini wells with dimensions of 
approximately 1 mm x 1 mm each separated by 0.2 mm. Paraffin oil was then added 
to cover all mini wells followed by the injection of individual protein solution into the 
mini well underneath the surface of the oil (Fig. 1, Scheme 2).  The sample was then 
incubated at room temperature (22 oC). The ATR-FTIR images were acquired using a 
continuous scan FTIR spectrometer in combination with a 64 x 64 pixel focal plane 
array (FPA) detector. The number of inactive detector elements was less than 2 %. 
The background spectra were collected with a clean ATR crystal (i.e. without sample 
present). The ATR-FTIR imaging spectrometer is patented by Varian.13 The spectral 
resolution measured was 8 cm-1. 64 co-added interferograms were used to achieve a 
good signal to noise ratio which requires approximately 100 seconds for the 
simultaneous acquisition of 4096 infrared spectra.    
 
RESULTS AND DISCUSSION 
Strategy of sample deposition. The arrangements of the ATR measurement are 
illustrated in the schematic diagram (Schemes 1 and 2 in Fig. 1). Any substances that 
came close to the ATR measuring surfaces (within a few micrometers) within the 
field of view were captured in the image. There are two possible schemes for the 
sample deposition. Scheme 1 shows the deposition of the protein solution before 
submerging in paraffin oil which provides better control of the location of the protein 
solution on the measuring surface. Scheme 2 shows depositing the sample drop on the 
measuring surface which is already covered with paraffin oil. This reduces the amount 
of water evaporation giving more control of the concentration in the solution, during 
the sample deposition procedure. Since a typical protein solution has a higher density 
than the oil, the sample drop sinks to the measuring surface automatically. ATR-FTIR 
imaging measurements of sample prepared following the procedure described in 
Scheme 2 showed no detectable amount of oil present between the measuring surface 
and the protein solution. It should be noted that the penetration depth of the 
evanescent wave of the ATR-FTIR imaging approach depends on the refractive index 
of the medium.  This may complicate its use in studies of multi-component systems.  
However, the difference in refractive indices here is not significant since the 
refractive index, n, for water is 1.33 and for proteins is 1.45 -1.5. From our previous 
ATR-FTIR imaging studies in aqueous solutions (e.g. tablet dissolution, diffusion, 
wet tissue studies10, 11and  live cancer cells,14) this difference does not significantly 
affect the results as ATR-FTIR imaging probes the surface layer of the sample which 
has a thickness of only several micrometers.  
 
Model study – a feasibility test. The feasibility of this measurement approach was 
first examined using the crystallization of lysozyme from a supersaturated solution 
which is the bench-mark for new protein crystallization techniques. 60 mg/mL 
lysozyme protein solution in sodium acetate buffer pH 4.6 was supersaturated by 
injecting an equal amount of precipitant solution containing 6 % NaCl to the sample 
protein solution. Under these conditions, lysozyme crystallizes within 1 day of 
incubation. Scheme 1 was applied in this experiment. After 1 day of incubation, 
crystals were formed from the solution and the visible image is shown in Fig. 2b. The 
corresponding ATR-FTIR image is shown in Fig. 2a. The ATR-FTIR image is 
generated by plotting the distribution of the absorbance of the protein-specific amide 
II band at 1550 cm-1 across the whole imaged area. The colour on the image 
corresponds to the absorbance of the specific band chosen. Red regions shown in the 
image represent a high protein concentration in those areas, thus giving direct 
evidence that the precipitated crystals are protein. The location of the crystal shown in 
the visible image (Fig. 2b) coincides well with the FTIR image indicating that most of 
the protein crystals were formed very close to the measuring surface and were 
measured by this imaging method. From Fig. 2c, which is an overlay of Fig. 2a and 
2b, the percentage of crystals captured by this imaging method was determined to be 
approximately 90 % for this particular protein. There are slight mismatches for three 
of the protein crystals which are circled in Fig. 2c. Since the visible image was taken 
after the ATR-FTIR measurement, they could be caused by migration of these three 
crystals during movement of the ATR accessory between spectrometer and 
microscope. Using the same procedure, protein crystals of thaumtin were also 
detected (data not shown, as results are similar to those in Fig. 2). These simple 
experiments demonstrate that protein crystals can be detected once they are formed at 
the measuring surface and their authenticity can be verified by their infrared spectra.  
These crystals were not used for x-ray, but rather informed our choices in crystal 
optimization to achieve x-rayable crystals for subsequent analysis.  
 
 
High-throughput application.  The ATR-FTIR image in Fig. 2 showed that there are 
large redundant areas in the image field of view that may be utilised to measure more 
than one sample at a time. We have previously demonstrated that ATR-FTIR imaging 
is suitable for high-throughput experiments,15 thus allowing screening to be done in 
parallel with precipitate identification. Sample preparation is simple as samples only 
need to make contact with the surface of the ATR element. To prevent cross 
contamination, samples were separated by the mean of a grid which was constructed 
by printing a wax wall array (solid at room temperature) from heated wax directly 
onto the ATR element which formed 6 mini wells within the imaging area. Samples 
were deposited manually into each mini well but it could also be deposited with a 
robotic arm.15 Scheme 2 was applied in this study. Fig. 3 shows the ATR-FTIR result 
for 6 lysozyme solutions (even more samples may be screened in the same batch as 
discussed below). Each of the samples contained different protein and salt 
concentrations. In Fig. 3a, the locations of the sample are marked by the blue area in 
the oil distribution image. Note that the image shows no oil penetrated into the protein 
solution drop or the interface between the protein solution and the ATR measuring 
surface. All pixels on the image were measured simultaneously and all samples were 
essentially under identical conditions, allowing direct comparison of the 
crystallization process between protein solutions of different formulation to be made. 
There was no protein crystal present at the beginning of the experiment as 
demonstrated in Fig. 3b which was generated by plotting the absorbance of the amide 
II band. The image taken 18 h after the initiation of supersaturation (Fig. 3c) showed 
that only the sample with 30 mg/ml protein and 3.5 % NaCl formed some protein 
crystals. The high-throughput study showed that this imaging method can be used as a 
tool to screen multiple samples and conditions for growing large monolith protein 
crystals.  
 
Diamond ATR accessory for higher spatial resolution imaging. The spatial 
resolution of the FTIR images presented in Fig. 2 and 3 was approximately 40 μm 
because a relatively large inverted prism made of ZnSe was used, meaning that 
protein crystals were detected only when they grew to a size of 40 μm or larger. ATR-
FTIR imaging with better spatial resolution would extend the application of this 
imaging method to detect protein crystals that grow to limited sizes or to detect early 
stages of crystalllisationcrystallization. Previous work has demonstrated that it is 
possible to obtain ATR-FTIR images with higher spatial resolution that can resolve 
features as small as 12 μm using a diamond ATR accessory with 4x magnification 
optics.14, 16, 17 The same lysozyme protein solution was used in this demonstration and 
Scheme 1 was applied in this experiment. Fig. 4 shows the result of the in situ 
measurement of lysozyme protein crystallization using such an accessory. The image 
was measured 5 h after the initiation of supersaturation by mixing the protein solution 
with the salt solution. By using this accessory, smaller crystals which were not 
detected using the inverted ZnSe prism were now detectable. By improving the spatial 
resolution with imaging optics, the sensitivity of this method was increased. The 
overlaid image showed a 100% overlap between the visible and ATR-FTIR image. 
Nevertheless, the use of an inverted ZnSe prism is probably more suitable for high-
throughput studies because it images a greater field of view.  
 
The number of solutions that can be studied in a single batch is limited by the imaging 
area. The size of the image is limited by the size of the detector and the measuring 
internal reflection element available. The current detector contains 64 x 64 pixels 
offering a field of view of approximately 2.5 mm x 3.6 mm which is a fraction of the 
area of the ZnSe internal reflection element that is used for imaging purposes. A 
recent development of this ATR-FTIR imaging technique allows the internal 
reflection element to be translated along or across the infrared beam which enables 
different parts of the crystal surface to be imaged.18  It has been demonstrated that the 
area that can be surveyed in the current setup was over 10 times the size of the image 
shown in Fig. 2. It would therefore be possible to screen over 60 protein solutions in 
one experiment using this imaging technology. 
 
Crystallization of thaumatin. To demonstrate the feasibility of applying this method 
to study the crystallization of more challengingother proteins, thaumatin was 
crystallized and measured using the same procedure developed. The protein was set to 
crystallize on both the ZnSe ATR accessory and the diamond ATR accessory. 
Crystals of ~100 μm and ~10-40 μm in length were formed 48 hours and 24 hours 
after the initiation of crystallization on the two surfaces, respectively on the ZnSe and 
diamond surfaces.  Spectra extracted from the area where these crystals were located 
have confirmed that they were protein crystals. The image generated by plotting the 
absorbance of the amide II band across the imaged area reveals the location of these 
protein crystals. The ATR-FTIR images have beenwere overlaid with the 
corresponding visible images and the results (shown in Fig. 5) confirm that the spectra 
extracted were measured from the crystal deposit. This experiment ensuressupports 
that thisthe wider applicability of our imaging method is suitable for different protein 
solutions.   
 
 
Membrane protein study. To demonstrate how this approach could aid protein 
crystallization studies for challenging membrane protein targets, human CD81, was 
studied which is a member of the tetraspanin family of 4 transmembrane domain 
proteins. These proteins are involved in multiple biological functions, including cell 
proliferation and cell-cell adhesion, as well as being key players in cancer, the 
immune system, fertilisation and several infectious diseases including Hepatitis C.19 
Consequently CD81 and its family members are hot drug targets. Unfortunately, the 
production of recombinant human membrane proteins in yields sufficient for crystal 
trials is an enduring bottleneck in modern structural genomics programmes with 
CD81 being one of only relatively few examples that can be produced in a functional 
form in milligramme quantities.12 Consequently the number of membrane protein 
structures is tiny compared to the situation for soluble proteins.  
 
Crystalline structures with dimensions of ~20 x 50 x 5 μm were formed after 24 h 
incubation but it was not possible to determine the identity of these crystals by light 
microscopy alone (see Fig. 65a). Spectra extracted from the “crystal” regions, which 
are shown in Fig. 65b, did not resemble the spectrum of protein. Hence, it was clear 
that these were not protein crystals, as confirmed by x-ray diffraction which showed 
the crystals to be salt. 
 
 
CONCLUSIONS 
 
The experiments described above have clearly demonstrated that ATR-FTIR imaging 
can be a valuable tool, readily applicable to protein crystallization research which 
reduces the cost and effort required for the identification of protein crystals. It 
definitively determines if a ‘lead’ obtained in a screen is worth optimising.  The main 
advantage of this technique is that identification of protein crystals can be performed 
in situ, as the crystals form, without the need to disturb the sample. This is especially 
important when crystallizing challenging proteins from complex systems such as 
thaumatin and the one demonstrated in the membrane protein study. When crystals 
are formed, the spectrum extracted from the image can be used as a direct indicator to 
distinguish protein from salt or precipitants. For screening purposes, this method is 
even superior to x-raying the crystals which requires the crystal to have a minimum 
size in 3 dimensions.  In contrast ATR-FTIR imaging can detect whether a crystal is 
comprised of protein even if it is essentially a 2D crystal, with a thickness in the z-
direction of only 1 μm. The possibility of applying this method in a high-throughput 
manner is particularly exciting as it will determine which conditions are worth 
pursuing for further crystal optimisation to yield high quality x-rayable protein 
crystals for structure analysis.  
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Figure 1: Schematic diagram showing different strategies for sample deposition. 
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Figure 2: ATR-FTIR image (imaged area is approximately 2.5 x 3. 6 mm2) (a) of the 
protein crystal formed on the measuring surface 20 h after the introduction of the 
crystallizing agent. Red represents high protein concentration. The visible image (b) 
shows the protein crystals formed coincide well with the location of the red spots on 
the ATR-FTIR image. (c) Result of overlaying images (a) and (b). 5 out of 50 crystals 
(highlighted with arrows) were not captured in the ATR-FTIR image and 3 crystals 
(circled) were mislocated .  
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Figure 3: ATR-FTIR images of 6 different super-saturated lysozyme protein solutions 
at different concentrations. Image (a) represents the distribution of the surrounding 
paraffin oil, images (b) and (c) represent the distribution of protein (based on the 
amide II absorbance) at different times after the initial deposition.  
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Figure 4: ATR-FTIR image (left) of the protein crystals formed on the measuring 
surface 5 h after the introduction of the crystallizing agent. Red represents high 
protein concentration. The visible image with the ATR-FTIR image overlaid (right) 
shows the area of measurement. The protein crystals formed coincide well with the 
location of the red spot on the ATR-FTIR image.  
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Figure 5: ATR-FTIR images (top row) of the protein (thaumatin) crystals formed on 
the a) measuring surface of the ZnSe ATR accessory and b) measuring surface of the 
diamond ATR accessory 48 and 24 hours, respectively, after the introduction of the 
crystallising agent. Red represents high protein concentration. The visible images 
(middle row) and the overlay of the ATR-FTIR/ and visible image overlaids (bottom 
row) shows the area of measurement and that the protein crystals formed coincide 
well with the locations of the red spots on the ATR-FTIR image.  
2.56 mm 
a)  b)  
0.6 mm 
    
 
 
Figure 65: a) Visible image of crystal-like precipitate from the supersaturated CD81 
protein solution. The length of the scale bar is 100 μm. b) ATR-FTIR spectrum 
extracted from the crystal-like area of the imaging measurement.  
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